Crossmark Global Holdings Inc. reduced its position in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 13.8% in the 4th quarter, HoldingsChannel reports. The firm owned 12,406 shares of the company’s stock after selling 1,992 shares during the period. Crossmark Global Holdings Inc.’s holdings in Henry Schein were worth $974,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently made changes to their positions in the company. Bell Asset Management Ltd increased its holdings in shares of Henry Schein by 5.0% during the third quarter. Bell Asset Management Ltd now owns 114,872 shares of the company’s stock worth $9,768,000 after buying an additional 5,508 shares in the last quarter. Oppenheimer Asset Management Inc. increased its holdings in shares of Henry Schein by 6.1% during the third quarter. Oppenheimer Asset Management Inc. now owns 63,284 shares of the company’s stock worth $5,381,000 after buying an additional 3,642 shares in the last quarter. Coastline Trust Co increased its holdings in shares of Henry Schein by 4.1% during the third quarter. Coastline Trust Co now owns 24,110 shares of the company’s stock worth $2,050,000 after buying an additional 940 shares in the last quarter. Howland Capital Management LLC acquired a new position in shares of Henry Schein during the third quarter worth $207,000. Finally, AMG National Trust Bank increased its holdings in shares of Henry Schein by 4.5% during the third quarter. AMG National Trust Bank now owns 31,435 shares of the company’s stock worth $2,673,000 after buying an additional 1,355 shares in the last quarter.
Shares of Henry Schein stock opened at $59.15 on Monday. The company has a current ratio of 1.30, a quick ratio of 0.70 and a debt-to-equity ratio of 0.29. Henry Schein, Inc. has a twelve month low of $57.78 and a twelve month high of $91.35. The firm has a market capitalization of $9.02 billion, a P/E ratio of 16.43, a price-to-earnings-growth ratio of 1.86 and a beta of 0.89.
Henry Schein announced that its Board of Directors has approved a share buyback plan on Thursday, December 13th that permits the company to buyback $400.00 million in outstanding shares. This buyback authorization permits the company to buy up to 3.1% of its shares through open market purchases. Shares buyback plans are typically a sign that the company’s management believes its stock is undervalued.
Several brokerages have recently issued reports on HSIC. ValuEngine downgraded shares of Henry Schein from a “sell” rating to a “strong sell” rating in a report on Sunday. Zacks Investment Research downgraded shares of Henry Schein from a “hold” rating to a “sell” rating in a report on Tuesday, January 8th. Piper Jaffray Companies reiterated an “overweight” rating and set a $96.00 price target on shares of Henry Schein in a report on Thursday, November 29th. BidaskClub downgraded shares of Henry Schein from a “strong-buy” rating to a “buy” rating in a report on Tuesday, October 23rd. Finally, Evercore ISI downgraded shares of Henry Schein from an “in-line” rating to an “underperform” rating and set a $76.39 price target for the company. in a report on Thursday, January 3rd. Six research analysts have rated the stock with a sell rating, eight have issued a hold rating and six have given a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average price target of $84.19.
In related news, insider David Mckinley sold 8,321 shares of the business’s stock in a transaction on Friday, November 30th. The shares were sold at an average price of $88.77, for a total value of $738,655.17. Following the sale, the insider now owns 68,012 shares of the company’s stock, valued at $6,037,425.24. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, SVP Michael S. Ettinger sold 7,425 shares of the business’s stock in a transaction on Monday, December 10th. The stock was sold at an average price of $84.36, for a total transaction of $626,373.00. Following the completion of the sale, the senior vice president now directly owns 72,143 shares in the company, valued at approximately $6,085,983.48. The disclosure for this sale can be found here. In the last three months, insiders sold 105,856 shares of company stock worth $9,222,275. 1.15% of the stock is currently owned by insiders.
Henry Schein Profile
Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, animal health clinics, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
See Also: What is systematic risk?
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.